FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and concerns preparation of a cell transplantation material in myelosuppression. That is ensured by subcutaneous introduction to a laboratory animal of a recombinant granulocytic colony-stimulating factor (G-CSF) in dosage 125 mcg/kg once a day for 3 days. It is combined with intraperitoneal introduction of hyaluronidase in dosage 1000 SU/kg once a day for 2 days. Then mononuclear leukocyte fraction of peripheral blood is prepared, placed in a balanced nutrient medium containing 10-8 mol/ml of D-glucuronic acid, and incubated for 2 hours.
EFFECT: introduction of G-CSF and hyaluronidase in the developed dosage and regimen, in combination with incubation with D-glucuronic acid added provides higher therapeutic activity of the graft due to mononuclear growth in peripheral blood and better engrafting ability.
1 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
METHOD FOR STIMULATING MYELOGENESIS | 2010 |
|
RU2442589C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
Authors
Dates
2010-06-27—Published
2008-11-05—Filed